862
Vol. 56, No. 6
methylhexadecanoic acid, was cited in the literature as a
patent11) describing surfactant properties of mid-chain
branched fatty acids, although the compound was not a natu-
ral product.
Experimental
General Procedures Optical rotation was measured using a JASCO
DIP-370 automatic polarimeter. IR spectra were recorded using a Perkin-
Elmer FT-IR PARAGON 1000 spectrophotometer. All NMR spectra were
taken using a Bruker DRX-500 (1H; 500 MHz, 13C; 125 MHz) spectrometer.
1H–1H COSY, NOESY, HMQC and HMBC spectra were measured using
standard Bruker pulse sequences. Chemical shifts are given on a d (ppm)
scale with CHCl3 (1H; 7.26 ppm) and CDCl3 (13C; 77.0 ppm) as the internal
standard. High-resolution ESI mass spectra were taken using a Micromass
LCT spectrometer.
Chart 1. Chemical Conversion of 1
Extraction and Isolation Wet specimens (1.6 kg) of the soft coral of
the genus Sinularia, collected from the coral reef off Ishigaki Island (Oki-
nawa, Japan), were extracted with MeOH (4.0 l, three times). Each MeOH
extract was concentrated under reduced pressure. The combined MeOH ex-
tract (71.2 g) was partitioned between EtOAc and H2O. The EtOAc soluble
portion (9.4 g) was chromatographed on a silica gel column (100 g) eluted
with hexane (600 ml, fraction A), hexane–EtOAc (3 : 1, 600 ml, fraction
B), hexane–EtOAc (1 : 1, 600 ml, fraction C), EtOAc (600 ml, fraction
D), and MeOH (600 ml, fraction E), to give five fractions. A part (2.0 g)
of fraction B (4.5 g) was subjected to flash column chromatography
(hexane–EtOAcꢁ9 : 1, 8.5 : 1.5, 8 : 2, 7.5 : 2.5, 7 : 3, 6.5 : 3.5 and EtOAc) to
give 13 fractions. The third fraction (580 mg) was further purified by nor-
mal-phase (hexane–EtOAcꢁ8 : 2) and reversed-phase HPLC (ODS,
MeOH–H2Oꢁ95 : 5, 9 : 1, tetrahydrofuran–H2Oꢁ6 : 4) to give compound 1
(124 mg).
Fig. 3. Structures of RR- and SS-2Acyclo-OH of 1
for 1.
(E,R)-6,7-Dimethylhexadec-7-enoic Acid (1): Colorless oil; [a]D25 ꢀ1.0°
(cꢁ3.86, CHCl3); IR (film) nmax 3200—2500 (broad), 2920, 1714 cmꢀ1
;
13C-
The position of the trisubstituted double bond in 1 was
confirmed by the following chemical conversion (Chart 1).
Compound 1 was converted to methyl ester 2, which was
treated with osmium oxide (VIII) and periodic acid hydrate
at room temperature to give aldehyde 3 and ketoester 4.
Without purification of the products, the mixture was treated
with 2,4-dinitrophenylhydrazine to give corresponding 2,4-
dinitrophenylhydrazones 5 and 6. The structures of 5
(C15H22N4O4) and 6 (C16H22N4O6) were elucidated by the MS
and NMR data. Thus the presence of a trisubstituted double
bond between C-7 and C-8 in 1 was established.
1
and H-NMR, see Table 1; HR-ESI-MS m/z: 283.2633 [MꢂH]ꢂ (Calcd for
C18H35O2, 283.2637).
Conversion of 1 to Phenylhydrazones 5 and 6 Compound 1 was
methylated to methyl ester 2 by the treatment of 1 with CH2N2 in diethyl
ether. A small amount of H5IO4 (total 34 mg) and 30% AcOH solution (total
50 ml) were added to a mixture of 2 (17 mg) and H2O–t-BuOH (1 : 1,
500 ml). The reaction mixture was stirred at room temperature for 2 h. After
the addition of 0.05 M aqueous NaOH solution to pH 6, 2,4-dinitrophenylhy-
drazine (65 mg) in a 5% aqueous H3PO4 solution was added. The reaction
mixture was extracted with diethyl ether and the organic layer was washed
successively with water twice and brine twice, and was dried over anhydrous
MgSO4. After filtration, the filtrate was concentrated under reduced pres-
sure. The residue was chromatographed on a silica gel column. Elution with
hexane–EtOAc (9 : 1) gave two fractions. Each fraction was further purified
by normal-phase HPLC (hexane–EtOAcꢁ9 : 1) to give compound 5 (3.5 mg)
from the first fraction and compound 6 (5.3 mg) from the second fraction.
The E configuration of the double bond at C-7 was dis-
closed by the NOE correlations between H-8 and H3-17 and
H2-9 and H3-18 (Fig. 2). The absolute stereochemistry of the
chiral center at C-6 bearing a methyl group was determined
1
Compound 5: Yellow amorphous solids; H-NMR (300 MHz, CDCl3), d
based on the Ohrui–Akasaka method.10) The method clarifies ppm: 0.89 (3H, s), 1.24—1.38 (10H, m), 1.60 (2H, m), 2.42 (2H, dt, Jꢁ5.4,
7.3 Hz), 7.53 (1H, t, Jꢁ5.4 Hz), 7.92 (1H, d, Jꢁ9.6 Hz), 8.29 (1H, dd,
both the position and absolute configuration of a branched
methyl group on a long-chain fatty acid based on the reten-
tion times of ester derivatives prepared from a fatty acid
Jꢁ2.6, 9.6 Hz), 9.12 (1H, d, Jꢁ2.6 Hz), 11.02 (1H, s, NH); 13C-NMR
(75 MHz, CDCl3), d ppm: 14.1 (CH3), 22.6 (CH2), 26.3 (CH2), 29.2 (CH2),
29.3 (CH2), 29.7 (CH2), 31.8 (CH2), 32.5 (CH2), 116.5 (CH), 123.5 (CH),
and RR- and SS-trans-2-(2,3-anthracenedicarboximido)cyclo-
hexanol in reverse-phase HPLC. When compound 1 has a 6R
configuration, RR-trans-2-(2,3-anthracenedicarboximido)cy-
clohexanol (RR-2Acyclo-OH) of 1, in which the 6R-CH3 is
oriented over the plane of anthracene (Fig. 3), is predicted to
be eluted from reversed-phase column faster than the corre-
sponding SS derivative (SS-2Acyclo-OH) of 1, in which the
6R-CH3 is oriented off the plane of anthracene, based on the
theory of the Ohrui–Akasaka method. In fact, the reversed-
phase HPLC of the ester derivatives showed that RR-2Acy-
clo-OH derivative 7 was eluted faster than the SS-2Acyclo-
OH derivative 8, indicating the R configuration at C-6 in 1.
From these findings, compound 1 was assigned to be (E,R)-
6,7-dimethylhexadec-7-enoic acid. Compound 1 is the first
natural unsaturated fatty acid with a 2,3-dimethyl-1-propenyl
128.8 (C), 130.0 (CH), 137.7 (C), 145.1 (C), 152.7 (CH); HR-ESI-MS m/z:
323.1721 [MꢂH]ꢂ (Calcd for C15H23N4O4, 323.1719).
1
Compound 6: Yellow amorphous solids; H-NMR (300 MHz, CDCl3), d
ppm: 1.17 (3H, d, Jꢁ6.9 Hz), 1.32 (2H, m), 1.48 (1H, m), 1.64 (1H, m), 2.42
(2H, dt, Jꢁ5.4, 7.3 Hz), 7.53 (1H, t, Jꢁ5.4 Hz), 7.92 (1H, d, Jꢁ9.6 Hz), 8.29
(1H, dd, Jꢁ2.6, 9.6 Hz), 9.12 (1H, d, Jꢁ2.6 Hz), 11.02 (1H, s, NH); 13C-
NMR (75 MHz, CDCl3), d ppm: 13.5 (CH3), 17.9 (CH3), 24.9 (CH2), 26.9
(CH2), 33.6 (CH2), 33.8 (CH2), 42.4 (CH2), 51.5 (OCH3), 116.5 (CH), 123.5
(CH), 129.1 (C), 130.0 (CH), 137.7 (C), 145.3 (C), 161.3 (C), 173.6 (CO);
HR-ESI-MS m/z: 367.1637 [MꢂH]ꢂ (Calcd for C16H23N4O6, 367.1608).
Conversion of 1 to RR-2Acyclo-OH Derivative 7 and SS-2Acyclo-
OH Derivative 8 Compound 1 (1.3 mg) was reacted with RR-trans-2-
(2,3-anthracenedicarboximido)cyclohexanol (RR-2Acyclo-OH, 1.6 mg) in
toluene–CH3CN (1 : 1, 0.5 ml) in the presence of 1-ethyl-3-(3-dimethyl-
aminopropyl)carbodiimide hydrochloride (EDC, 2.1 mg) and 4-dimethyl-
aminopyridine (DMAP, 1.3 mg) at 40 °C for 13 h. The reaction mixture was
concentrated under reduced pressure and the residue was dissolved in
CHCl3–MeOH (1 : 1). The solution was passed through a silica gel short col-
unit. The structure of the dihydro derivative of 1, 6,7-di- umn, and the eluate was concentrated under reduced pressure. The residue